Italian Web-based Cross-sectional Survey on COVID-19

NCT04471701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200000

Last updated 2022-04-07

No results posted yet for this study

Summary

The outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that started in late December 2019 in the Hubei province of China caused millions of cases worldwide in just a few months, and evolved into a real pandemic.

However, only approximately 20% of SARS-CoV-2 infected patients required intensive on sub-intensice medical care and the remained experience mild or subclinical form of the disease that did not require hospital admission and a relatively high percentage (40 to 45%) remained asymptomatic.

Understanding the occurrence of SARS-CoV-2-like infectious in a large non-hospitalized population, when the epidemic peak was occurring in Italy, is of paramount importance but data are scarce.

The goal of this research project is to estimate the number of suspected cases of COVID-19 and to investigate the role of the potential factors associated with SARS-CoV-2 infection in a large Italian sample of respondents living in Italy during the lockdown (started in Italy on 9 March 2020).

EPICOVID19 is an Italian countrywide self-administered cross-sectional web-based survey on adult volunteers launched on April 13, 2020.

The on-line questionnaire has been developed starting from the available literature and implemented using an open source platform focusing on beahvioural and clinical features of participants.

Conditions

  • Covid19
  • SARS-CoV Infection
  • Survey, Family Life
  • Epidemic Disease
  • Self-Assessment

Interventions

BEHAVIORAL

Environmental exposure and clinical features

Environmental exposures and clinical features are measured by means of a self-administered 38-item on-line questionnaire containing mainly mandatory and closed questions divided into six sections: i) socio-demographic data; ii) clinical evaluation; iii) personal characteristics and health status; iv) housing conditions; v) lifestyle; and vi) behaviours following the lockdown.

Sponsors & Collaborators

  • National Research Council, Institute of Clinical Physiology, Italy

    collaborator OTHER
  • Institute of Neuroscience-National Research Council

    collaborator UNKNOWN
  • University of Milan

    collaborator OTHER
  • Italian Society of Gerontology and Geriatrics

    collaborator UNKNOWN
  • Italian Society for Infectious and Tropical Diseases

    collaborator UNKNOWN
  • Institute of Biomedical Technologies-National Research Council, Italy

    lead OTHER

Principal Investigators

  • Federica Prinelli, PhD · Institute of Biomedical Technologies-National Research Council

  • Fulvio Adorni, MPH · Institute of Biomedical Technologies-National Research Council

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-13
Primary Completion
2021-02-28
Completion
2021-02-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04471701 on ClinicalTrials.gov